Prithviraj Bose, MD

Prithviraj Bose, MD, discusses management strategies for patients with myelofibrosis who progress on ruxolitinib (Jakafi).

Prithviraj Bose, MD, associate professor in the Department of Leukemia of the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, discusses management strategies for patients with myelofibrosis who progress on ruxolitinib (Jakafi).

Prithviraj Bose, MD, discusses the utility of ruxolitinib in patients with myelofibrosis.

Prithviraj Bose, MD, discusses novel agents under investigation in myelofibrosis.

Prithviraj Bose, MD, discusses novel agents under investigation in myelofibrosis.

Prithviraj Bose, MD, discusses treatment for patients with progressive myelofibrosis.